Octahydro-1H-4,7-methanoinden-5-ol, 95.0%, 5g

(S)-1-(4-(tert-Butyl)phenyl)ethan-1-amine, 97%, 250mg

Methyl 2-Bromo-4-methoxybenzoate, 97.0%, 5g

(2-(4-(Methoxycarbonyl)piperidin-1-yl)pyrimidin-5-yl)boronic acid, 95.0%, 5g

Naphthalene-2,6-disulfonyl dichloride, 95.0%, 250mg

Idrossietilcellulosa, 200-450 mPas, polvere, 100 g, confezione di plastica.

Chlorodimethyl(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-n-octyl)silane>94.0%(GC)5g

2-(3,4-Dimethoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>98.0%(GC)(T)1g

propyl({[3-(trifluoromethyl)phenyl]methyl})amine, 95.0%, 2g

2-Hydroxy-5-(methylthio)benzaldehyde, 97.0%, 250mg

(1H-Indol-3-yl)-1-propanamine, 95.0%, 1g

1,5-Dichloro-2-fluoro-3-iodobenzene, 97%, 500mg

5-Fluorouracil, 98.0%, 5g